.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Healthtrust
Teva
Cantor Fitzgerald
Dow
Cipla
Deloitte
QuintilesIMS
Mallinckrodt
McKesson

Generated: June 22, 2017

DrugPatentWatch Database Preview

VIVLODEX Drug Profile

« Back to Dashboard

Which patents cover Vivlodex, and what generic Vivlodex alternatives are available?

Vivlodex is a drug marketed by Iroko Pharms Llc and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has eight patent family members in eight countries.

The generic ingredient in VIVLODEX is meloxicam. There are twenty-two drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the meloxicam profile page.

Summary for Tradename: VIVLODEX

Patents:2
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list86
Patent Applications: see list8,180
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VIVLODEX at DailyMed

Pharmacology for Tradename: VIVLODEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Iroko Pharms Llc
VIVLODEX
meloxicam
CAPSULE;ORAL207233-001Oct 22, 2015RXYesNo9,649,318► SubscribeY ► Subscribe
Iroko Pharms Llc
VIVLODEX
meloxicam
CAPSULE;ORAL207233-002Oct 22, 2015RXYesYes9,649,318► SubscribeY ► Subscribe
Iroko Pharms Llc
VIVLODEX
meloxicam
CAPSULE;ORAL207233-001Oct 22, 2015RXYesNo9,526,734► SubscribeY ► Subscribe
Iroko Pharms Llc
VIVLODEX
meloxicam
CAPSULE;ORAL207233-001Oct 22, 2015RXYesNo► Subscribe► Subscribe
Iroko Pharms Llc
VIVLODEX
meloxicam
CAPSULE;ORAL207233-002Oct 22, 2015RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: VIVLODEX

Drugname Dosage Strength RLD Submissiondate
meloxicamCapsules5 mg and 10 mgVivlodex1/9/2017

International Patent Family for Tradename: VIVLODEX

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2015191595► Subscribe
Canada2951383► Subscribe
African Regional IP Organization (ARIPO)201609611► Subscribe
Singapore11201610179Q► Subscribe
Uruguay36172► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chubb
McKinsey
Express Scripts
Citi
US Army
US Department of Justice
Julphar
Harvard Business School
Deloitte
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot